XML 89 R27.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Acquisitions and Acquisition-Related Items (Tables) | 6 Months Ended
--- | ---
Oct. 30, 2015
Business Acquisition [Line Items] |
Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs | The recurring Level 3 fair value measurements of contingent consideration include the following significant unobservable inputs:
|  | Fair Value at |  |  |  |  |  |
($ in millions) |  | October 30, 2015 |  | Valuation Technique |  | Unobservable Input |  | Range
|  |  |  |  |  | Discount rate |  | 11% - 27.2%
Revenue-based payments |  | $203 |  | Discounted cash flow |  | Probability of payment |  | 30% - 100%
|  |  |  |  |  | Projected fiscal year of payment |  | 2016 - 2025
|  |  |  |  |  | Discount rate |  | 0.6% - 5.5%
Product development-based payments |  | $165 |  | Discounted cash flow |  | Probability of payment |  | 15% - 100%
|  |  |  |  |  | Projected fiscal year of payment |  | 2016 - 2020
Reconciliation of Beginning and Ending Balances of Contingent Consideration Associated with Acquisitions | The following table provides a reconciliation of the beginning and ending balances of contingent consideration associated with acquisitions subsequent to April 24, 2009:
| Three months ended |  | Six months ended
(in millions) | October 30, 2015 |  | October 24, 2014 |  | October 30, 2015 |  | October 24, 2014
Beginning Balance | $ | 291 |  |  | $ | 87 |  |  | $ | 264 |  |  | $ | 68 |
Purchase price contingent consideration | 109 |  |  | — |  |  | 135 |  |  | 23 |
Contingent consideration payments | (17 | ) |  | — |  |  | (20 | ) |  | (5 | )
Change in fair value of contingent consideration | (15 | ) |  | 4 |  |  | (11 | ) |  | 5 |
Ending Balance | $ | 368 |  |  | $ | 91 |  |  | $ | 368 |  |  | $ | 91 |
Covidien plc [Member] |
Business Acquisition [Line Items] |
Fair Value of Assets Acquired and Liabilities Assumed | The preliminary fair values of the assets acquired and liabilities assumed in connection with the Transactions are as follows:
(estimated in millions) | January 26, 2015 (as previously reported) |  | Adjustments |  | January 26, 2015 (as adjusted)
Accounts receivable | $ | 1,349 |  |  | $ | — |  |  | $ | 1,349 |
Inventories | 2,222 |  |  | (1 | ) |  | 2,221 |
Other current assets | 2,949 |  |  | 185 |  |  | 3,134 |
Property, plant, and equipment | 2,354 |  |  | (21 | ) |  | 2,333 |
Goodwill | 29,586 |  |  | 22 |  |  | 29,608 |
Intangible assets | 26,265 |  |  | (71 | ) |  | 26,194 |
Other assets | 747 |  |  | 24 |  |  | 771 |
Total assets acquired | 65,472 |  |  | 138 |  |  | 65,610 |
Short-term borrowings | 1,011 |  |  | — |  |  | 1,011 |
Other current liabilities | 2,331 |  |  | 87 |  |  | 2,418 |
Long-term debt | 4,623 |  |  | — |  |  | 4,623 |
Long-term deferred tax liabilities | 4,736 |  |  | 73 |  |  | 4,809 |
Other long-term liabilities | 2,783 |  |  | (22 | ) |  | 2,761 |
Total liabilities assumed | 15,484 |  |  | 138 |  |  | 15,622 |
Net assets acquired | $ | 49,988 |  |  | $ | — |  |  | $ | 49,988 |
Acquisitions 2016 [Member] |
Business Acquisition [Line Items] |
Fair Value of Assets Acquired and Liabilities Assumed | The fair values of the assets acquired and liabilities assumed during the six months ended October 30, 2015 are as follows:
(in millions) | Twelve, Inc. |  | RF Surgical Systems, Inc. |  | Medina Medical |  | All Other |  | Total
Other current assets | $ | 60 |  |  | $ | 43 |  |  | $ | 11 |  |  | $ | 33 |  |  | $ | 147 |
Property, plant, and equipment | — |  |  | 3 |  |  | — |  |  | 4 |  |  | 7 |
IPR&D | 192 |  |  | — |  |  | 122 |  |  | 108 |  |  | 422 |
Other intangible assets | — |  |  | 115 |  |  | — |  |  | 120 |  |  | 235 |
Goodwill | 301 |  |  | 132 |  |  | 126 |  |  | 170 |  |  | 729 |
Other assets | — |  |  | 2 |  |  | — |  |  | 6 |  |  | 8 |
Total assets acquired | 553 |  |  | 295 |  |  | 259 |  |  | 441 |  |  | 1,548 |
Current liabilities | 37 |  |  | 28 |  |  | 6 |  |  | 17 |  |  | 88 |
Long-term deferred tax liabilities, net | 44 |  |  | 27 |  |  | 34 |  |  | 29 |  |  | 134 |
Other liabilities | — |  |  | — |  |  | — |  |  | 2 |  |  | 2 |
Total liabilities assumed | 81 |  |  | 55 |  |  | 40 |  |  | 48 |  |  | 224 |
Net assets acquired | $ | 472 |  |  | $ | 240 |  |  | $ | 219 |  |  | $ | 393 |  |  | $ | 1,324 |
Acquisitions 2015 [Member] |
Business Acquisition [Line Items] |
Fair Value of Assets Acquired and Liabilities Assumed | The fair values of the assets acquired and liabilities assumed from acquisitions during fiscal year 2015, other than the Covidien acquisition, are as follows:
(in millions) | NGC Medical S.p.A. |  | Sapiens Steering Brain Stimulation |  | All Other |  | Total
Other current assets | $ | 55 |  |  | $ | 3 |  |  | $ | 12 |  |  | $ | 70 |
Property, plant, and equipment | 15 |  |  | 1 |  |  | 2 |  |  | 18 |
IPR&D | — |  |  | 30 |  |  | 41 |  |  | 71 |
Other intangible assets | 159 |  |  | — |  |  | 157 |  |  | 316 |
Goodwill | 197 |  |  | 170 |  |  | 106 |  |  | 473 |
Other assets | 3 |  |  | 3 |  |  | 49 |  |  | 55 |
Total assets acquired | 429 |  |  | 207 |  |  | 367 |  |  | 1,003 |
Current liabilities | 34 |  |  | 4 |  |  | 6 |  |  | 44 |
Long-term deferred tax liabilities, net | 51 |  |  | — |  |  | 66 |  |  | 117 |
Other liabilities | 4 |  |  | — |  |  | — |  |  | 4 |
Total liabilities assumed | 89 |  |  | 4 |  |  | 72 |  |  | 165 |
Net assets acquired | $ | 340 |  |  | $ | 203 |  |  | $ | 295 |  |  | $ | 838 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quantitative information about the inputs used in the fair value measurement of liabilities. This disclosure may include, but is not limited to, the fair value of the liability, valuation technique used to measure fair value, the inputs used to measure fair value, the ranges of the inputs, and the weighted averages of the inputs. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mdt_CovidienPLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mdt_Acquisitions2016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mdt_Acquisitions2015Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |